Murine cry1 and cry2 gene deletions are associated with disruptions in the circadian rhythmicity of insulin and glucagon secretion, which in turn are associated with insulin resistance, hypertension and impaired glucose tolerance and dyslipidemia (106, 107). This evidence concerns the gene INS and metabolic syndrome.